Trending:
Analysis
-
![Cancer drug]()
The ten most promising cancer drugs being trialled
To meet rising demand, companies worldwide are striving to develop cost-effective and innovative therapies for a wide variety of cancer types. Pharmaceutical-technology.com lists some of the most promising oncology drugs...
-
![]()
A formula for success: inside Swiss pharma
Two of the world’s leading pharmaceutical companies, Novartis and Roche, call Switzerland home. So why have these giants, along with many other serious players in the industry, found the Swiss...
-
![]()
Gut instinct: how common drugs affect the microbiome
New research from the European Molecular Biology Laboratory has found that one in four non-antibiotic drugs affect the growth of bacteria in the gut. This could be a serious issue...
-
![]()
Unlocking cell-free protein synthesis: biotech’s next big ticket?
A Northwestern University-led research team has invented a new method of manufacturing proteins outside of a cell, an innovation with major implications for biotech. Abi Millar speaks to the team...
-
![]()
Can AI reveal complex patterns in biological data?
Can artificial intelligence be used to extract genomic data and discover relevant biomarkers? Immune-focused AI technology company CytoReason thinks so. Sally Turner finds out more from co-founder and president David...
-
![]()
Bipolar disorder: understanding a multifaceted mental condition
Bipolar disorder is a complex and much-misunderstood condition, which has been re-classified throughout history and to date. This special timeline feature tracks the scientific community’s growing understanding of the condition,...
-
![]()
Visualising biologics discovery: dealing with complex data
UK-based Dotmatics has announced a new version of its data visualisation tool, Vortex for Bioinformatics, bringing visualisation and informatics tools into the hands of ordinary lab scientists. Abi Millar finds...
-
![]()
May’s top news stories
The US Congress passed a ‘right-to-try’ bill that would allow terminally ill patients to seek drugs that are experimental and not fully approved by the US FDA directly from pharmaceutical...
-
![]()
How India’s use of unapproved antibiotics could undermine global health
New research has shown that unapproved antibiotics are rife in India, undermining the country’s efforts to tackle antimicrobial resistance. Elly Earls meets the study’s lead author Dr Patricia McGettigan to...
-
![]()
Can the gene and cell therapy revolution scale up?
A manufacturing capacity crunch is causing headaches for the burgeoning cell and gene therapy market. Smaller drug development firms will rely on contract manufacturing organisations to produce the viral vectors...
